About Tempus AI
Explore Tempus AI's innovative platform combining multimodal healthcare data with artificial intelligence to enhance precision medicine, clinical trials, and personalized patient care through tools like Tempus One and olivia.
Overview
- AI-Enabled Precision Medicine Platform: Tempus AI integrates artificial intelligence with multimodal clinical data to advance personalized healthcare solutions across oncology, cardiology, neuropsychology, and radiology.
- Largest Multimodal Healthcare Database: Maintains 200+ petabytes of structured molecular, imaging, and EHR data from 2,000+ healthcare institutions, enabling context-rich diagnostics and treatment insights.
- End-to-End Healthcare Solutions: Combines diagnostic testing labs (NGS sequencing), AI analytics platforms (Hub), and pharmaceutical R&D tools (TIME Trial matching) under one ecosystem.
Use Cases
- Oncology Treatment Optimization: Provides oncologists with biomarker-specific therapy recommendations via real-time analysis of genomic profiles against 95% of major pharma companies' drug pipelines.
- Pharmaceutical R&D Acceleration: Partners like Pfizer use Tempus' de-identified datasets (450+ unique data connections) to identify novel drug targets and optimize clinical trial recruitment.
- Population Health Management: Health systems leverage Tempus Next platform to automate care pathway adherence monitoring for conditions like structural heart disease.
Key Features
- Intelligent Diagnostics: Proprietary algorithms like Tumor Origin prediction incorporate longitudinal patient data with generative AI for context-aware test interpretations.
- Tempus One GenAI Suite: Enables natural language queries across unstructured medical records (pathology reports/imaging scans) for clinical trial matching and treatment timeline visualization.
- FDA-Cleared Medical Devices: Includes ECG-AF algorithm for atrial fibrillation risk detection and Olivia patient app for centralized health data management.
Final Recommendation
- Essential for Academic Medical Centers: 65% of US academic hospitals already utilize Tempus' platform for genomic testing integration with EHR systems.
- Strategic Partner for Biopharma Innovation: Unique combination of diagnostic infrastructure/curated datasets accelerates therapeutic development timelines.
- Valuable for Value-Based Care Initiatives: FDA-cleared AI tools like ECG-AF enable proactive intervention strategies while maintaining regulatory compliance.
